WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
SHZ · 000504.SZ · CNY
Stock price, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Landfar Bio-medicine Co., Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Landfar Bio-medicine Co., Ltd. Class A’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Landfar Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It also involves in the storage of biological resources, stem cells and immune cells. The company was founded in November 1988 and is headquartered in Changsha, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
HK$50.70+HK$0.05 (+0.1%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.37% below the high.
$97.73-$2.68 (-2.66%)
Kodiak Sciences Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
CN¥6.51-CN¥0.38 (-5.52%)
China Reform Health Management and Services Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.09% below the high.
$11.36-$1.38 (-10.83%)
Ginkgo Bioworks Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.65% below the high.
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
$0.62-$0.04 (-5.43%)
Filana Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.96% below the high.